YKL-40 expression in traumatic brain injury: An initial analysis

Journal of Neurotrauma

Volumn 27, Issue 7, 2010, Pages 1215-1223

  Bonneh Barkay, Dafna ^a   Zagadailov, Pavel ^b   Zou, Huichao ^b   Niyonkuru, Christian ^a   Figley, Matthew ^a   Starkey, Adam ^a   Wang, Guoji ^a   Bissel, Stephanie J ^a   Wiley, Clayton A ^a   Wagner, Amy K ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

chitinase; controlled cortical impact; cytokine; gliosis; neuroinflammation; traumatic brain injury; YKL 40

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHITINASE; INTERLEUKIN 1BETA; PROTEIN YKL 40; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN CONTUSION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; GLASGOW COMA SCALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFLAMMATION; INJURY SEVERITY; MACACA; MALE; MULTIPLE SCLEROSIS; PARIETAL LOBE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; SURVIVAL; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; FEMALE; GLYCOPROTEINS; HUMANS; LECTINS; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; RATS; RATS, SPRAGUE-DAWLEY; YOUNG ADULT;

EID: 77955074939     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1310     Document Type: Article

References (25)

1. Bell, M.J., Kochanek, P.M., Doughty, L.A., Carcillo, J.A., Adelson, P.D., Clark, R.S., Wisniewski, S.R., Whalen, M.J., and DeKosky, S.T. (1997). Interleukin-6 and interleukin-10 in ce-rebrospinal fluid after severe traumatic brain injury in children. J. Neurotrauma 14, 451-457.
2. Bonneh-Barkay, D., Bissel, S.J., Wang, G., Fish, K.N., Nicholl, G.C., Darko, S.W., Medina-Flores, R., Murphey-Corb, M., Rajakumar, P.A., Nyaundi, J., Mellors, J.W., Bowser, R., and Wiley, C.A. (2008). YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am. J. Pathol. 173, 130-143.
3. Buttram, S.D., Wisniewski, S.R., Jackson, E.K., Adelson, P.D., Feldman, K., Bayir, H., Berger, R.P., Clark, R.S., and Kocha-nek, P.M. (2007). Multiplex assessment of cytokine and che-mokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J. Neurotrauma 24, 1707-1717.
4. Chiaretti, A., Antonelli, A., Mastrangelo, A., Pezzotti, P., Tor-torolo, L., Tosi, F., and Genovese, O. (2008a). Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J. Neurotrauma 25, 225-234. (Pubitemid 351416742)
5. Chiaretti, A., Antonelli, A., Riccardi, R., Genovese, O., Pezzotti, P., Di Rocco, C., Tortorolo, L., and Piedimonte, G. (2008b). Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children. Eur. J. Paediatr. Neurol. 12, 195-204. (Pubitemid 351552048)
6. Dixon, C.E., Clifton, G.L., Lighthall, J.W., Yaghmai, A.A., and Hayes, R.L. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods. 39, 253-262.
7. Hayakata, T., Shiozaki, T., Tasaki, O., Ikegawa, H., Inoue, Y., Toshiyuki, F., Hosotubo, H., Kieko, F., Yamashita, T., Tanaka, H., Shimazu, T., and Sugimoto, H. (2004). Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 22, 102-107.
8. Hergenroeder, G., Redell, J.B., Moore, A.N., Dubinsky, W.P., Funk, R.T., Crommett, J., Clifton, G.L., Levine, R., Valadka, A., and Dash, P.K. (2008). Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intra-cranial pressure. J. Neurotrauma 25, 79-93.
9. Jennett, B., and Bond, M. (1975). Assessment of outcome after severe brain damage. Lancet 1, 480-484.
10. Johansen, J.S. (2006). Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan. Med. Bull. 53, 172-209.
11. Kirchhoff, C., Buhmann, S., Bogner, V., Stegmaier, J., Leidel, B.A., Braunstein, V., Mutschler, W., and Biberthaler, P. (2008). Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur. J. Med. Res. 13, 464-468.
12. Kirkpatrick, R.B., Emery, J.G., Connor, J.R., Dodds, R., Lysko, P.G., and Rosenberg, M. (1997). Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp. Cell Res. 237, 46-54.
13. Kline, A.E., Bolinger, B.D., Kochanek, P.M., Carlos, T.M., Yan, H.Q., Jenkins, L.W., Marion, D.W., and Dixon, C.E. (2002). Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats. Brain Res. 937, 22-31.
14. Laird, M.D., Vender, J.R., and Dhandapani, K.M. (2008). Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16, 154-164.
15. Lee, C.G., Hartl, D., Lee, G.R., Koller, B., Matsuura, H., Da Silva, C.A., Sohn, M.H., Cohn, L., Homer, R.J., Kozhich, A.A., Humbles, A., Kearley, J., Coyle, A., Chupp, G., Reed, J., Flavell, R.A., and Elias, J.A. (2009). Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J. Exp. Med. 206, 1149-1166.
16. Morganti-Kossmann, M.C., Satgunaseelan, L., Bye, N., and Kossmann, T. (2007). Modulation of immune response by head injury. Injury 38, 1392-1400.
17. Rehli, M., Niller, H.H., Ammon, C., Langmann, S., Schwarz-fischer, L., Andreesen, R., and Krause, S.W. (2003). Tran-scriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J. Biol. Chem. 278, 44058-44067.
18. Shiozaki, T., Hayakata, T., Tasaki, O., Hosotubo, H., Fuijita, K., Mouri, T., Tajima, G., Kajino, K., Nakae, H., Tanaka, H., Shimazu, T., and Sugimoto, H. (2005). Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 23, 406-410.
19. Shohami, E., Novikov, M., Bass, R., Yamin, A., and Gallily, R. (1994). Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 14, 615-619.
20. Shore, P.M., Thomas, N.J., Clark, R.S., Adelson, P.D., Wisniewski, S.R., Janesko, K.L., Bayir, H., Jackson, E.K., and Kochanek, P.M. (2004). Continuous versus intermittent cere-brospinal fluid drainage after severe traumatic brain injury in children: effect on biochemical markers. J. Neurotrauma 21, 1113-1122.
21. Singhal, A., Baker, A.J., Hare, G.M., Reinders, F.X., Schlichter, L.C., and Moulton, R.J. (2002). Association between cerebro-spinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J. Neurotrauma 19, 929-937.
22. Taupin, V., Toulmond, S., Serrano, A., Benavides, J., and Zavala, F. (1993). Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre-and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42, 177-185.
23. Waje-Andreassen, U., Krakenes, J., Ulvestad, E., Thomassen, L., Myhr, K.M., Aarseth, J., and Vedeler, C.A. (2005). IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol. Scand. 111, 360-365.
24. Zhou, Z., Peng, X., Insolera, R., Fink, D.J., and Mata, M. (2009a). IL-10 promotes neuronal survival following spinal cord injury. Exp. Neurol. 220, 183-190.
25. Zhou, Z., Peng, X., Insolera, R., Fink, D.J., and Mata, M. (2009b). Interleukin-10 provides direct trophic support to neurons. J. Neurochem. 110, 1617-1627.